European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
Smokers inhale more tar, nicotine and carbon monoxide when measured with WHO method RIVM has measured the amount of tar, nicotine and carbon monoxide (TNCO) in all filter cigarettes sold in the Netherlands with the WHO Intense method.
Concerns over falling vaccination coverage within National Immunisation Programme The percentage of children vaccinated within the National Immunisation Programme (NIP) has fallen for the second year in a row, according to the 2022 report ‘Vaccination Coverage and Annual Report of the Dutch National Immunisation Programme'. RIVM is concerned about this decline.
RIVM publishes new data from manufacturers on tobacco products On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
Darker cigarettes and other measures to make cigarettes less appealing There are a number of measures that can be implemented to make cigarettes less appealing and less addictive. For example, manufacturers could make cigarettes a darker colour. They could also stop using ingredients like sugars and flavourings.
RIVM prepares a recommended list of banned substances in tobacco products and e-cigarettes The goal of the European Tobacco Products Directive is to make tobacco products and e-cigarettes less harmful, addictive and attractive. The directive does not specifically state which substances are not allowed in tobacco products and e-cigarettes.
Number of tuberculosis patients in the Netherlands decreased slightly in 2022 compared to 2021 The number of people with tuberculosis (TB) in the Netherlands decreased slightly in 2022. In 2022, there were 635 TB patients in the Netherlands. This is six per cent fewer than in 2021, when there were 673 patients.
NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).